Literature DB >> 24218011

Transcriptional networks regulating the costamere, sarcomere, and other cytoskeletal structures in striated muscle.

Nelsa L Estrella1, Francisco J Naya.   

Abstract

Structural abnormalities in striated muscle have been observed in numerous transcription factor gain- and loss-of-function phenotypes in animal and cell culture model systems, indicating that transcription is important in regulating the cytoarchitecture. While most characterized cytoarchitectural defects are largely indistinguishable by histological and ultrastructural criteria, analysis of dysregulated gene expression in each mutant phenotype has yielded valuable information regarding specific structural gene programs that may be uniquely controlled by each of these transcription factors. Linking the formation and maintenance of each subcellular structure or subset of proteins within a cytoskeletal compartment to an overlapping but distinct transcription factor cohort may enable striated muscle to control cytoarchitectural function in an efficient and specific manner. Here we summarize the available evidence that connects transcription factors, those with established roles in striated muscle such as MEF2 and SRF, as well as other non-muscle transcription factors, to the regulation of a defined cytoskeletal structure. The notion that genes encoding proteins localized to the same subcellular compartment are coordinately transcriptionally regulated may prompt rationally designed approaches that target specific transcription factor pathways to correct structural defects in muscle disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24218011      PMCID: PMC3984630          DOI: 10.1007/s00018-013-1512-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  116 in total

1.  An initial blueprint for myogenic differentiation.

Authors:  Alexandre Blais; Mary Tsikitis; Diego Acosta-Alvear; Roded Sharan; Yuval Kluger; Brian David Dynlacht
Journal:  Genes Dev       Date:  2005-02-10       Impact factor: 11.361

2.  Histone methyltransferase Suv39h1 represses MyoD-stimulated myogenic differentiation.

Authors:  Asoke K Mal
Journal:  EMBO J       Date:  2006-07-13       Impact factor: 11.598

Review 3.  Dystrophin, its interactions with other proteins, and implications for muscular dystrophy.

Authors:  James M Ervasti
Journal:  Biochim Biophys Acta       Date:  2006-06-07

4.  JunB-CBFbeta signaling is essential to maintain sarcomeric Z-disc structure and when defective leads to heart failure.

Authors:  Benjamin Meder; Steffen Just; Britta Vogel; Jessica Rudloff; Linda Gärtner; Tillman Dahme; Inken Huttner; Alexandra Zankl; Hugo A Katus; Wolfgang Rottbauer
Journal:  J Cell Sci       Date:  2010-07-06       Impact factor: 5.285

Review 5.  Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy.

Authors:  Ahlke Heydemann; Elizabeth M McNally
Journal:  Trends Cardiovasc Med       Date:  2007-02       Impact factor: 6.677

6.  Myocyte-specific enhancer factor 2 acts cooperatively with a muscle activator region to regulate Drosophila tropomyosin gene muscle expression.

Authors:  M H Lin; H T Nguyen; C Dybala; R V Storti
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  Myocardin inhibits cellular proliferation by inhibiting NF-kappaB(p65)-dependent cell cycle progression.

Authors:  Ru-Hang Tang; Xi-Long Zheng; Thomas E Callis; William E Stansfield; Jiayin He; Albert S Baldwin; Da-Zhi Wang; Craig H Selzman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-22       Impact factor: 11.205

8.  Transcription of Drosophila troponin I gene is regulated by two conserved, functionally identical, synergistic elements.

Authors:  María-Cruz Marín; José-Rodrigo Rodríguez; Alberto Ferrús
Journal:  Mol Biol Cell       Date:  2004-01-12       Impact factor: 4.138

9.  Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy.

Authors:  Billy Chen; Lin Zhong; Sarah F Roush; Laura Pentassuglia; Xuyang Peng; Susan Samaras; Jeffrey M Davidson; Douglas B Sawyer; Chee Chew Lim
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

10.  The gene tinman is required for specification of the heart and visceral muscles in Drosophila.

Authors:  R Bodmer
Journal:  Development       Date:  1993-07       Impact factor: 6.868

View more
  13 in total

1.  MEF2D deficiency in neonatal cardiomyocytes triggers cell cycle re-entry and programmed cell death in vitro.

Authors:  Nelsa L Estrella; Amanda L Clark; Cody A Desjardins; Sarah E Nocco; Francisco J Naya
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

2.  Antagonistic regulation of cell-cycle and differentiation gene programs in neonatal cardiomyocytes by homologous MEF2 transcription factors.

Authors:  Cody A Desjardins; Francisco J Naya
Journal:  J Biol Chem       Date:  2017-05-04       Impact factor: 5.157

3.  MEF2 transcription factors regulate distinct gene programs in mammalian skeletal muscle differentiation.

Authors:  Nelsa L Estrella; Cody A Desjardins; Sarah E Nocco; Amanda L Clark; Yevgeniy Maksimenko; Francisco J Naya
Journal:  J Biol Chem       Date:  2014-11-21       Impact factor: 5.157

4.  Evidence for skeletal muscle fiber type-specific expressions of mechanosensors.

Authors:  Sebastian Mathes; Mathias Vanmunster; Wilhelm Bloch; Frank Suhr
Journal:  Cell Mol Life Sci       Date:  2019-01-30       Impact factor: 9.261

5.  MicroRNAs in the Myocyte Enhancer Factor 2 (MEF2)-regulated Gtl2-Dio3 Noncoding RNA Locus Promote Cardiomyocyte Proliferation by Targeting the Transcriptional Coactivator Cited2.

Authors:  Amanda L Clark; Francisco J Naya
Journal:  J Biol Chem       Date:  2015-08-03       Impact factor: 5.157

6.  The Function of the MEF2 Family of Transcription Factors in Cardiac Development, Cardiogenomics, and Direct Reprogramming.

Authors:  Cody A Desjardins; Francisco J Naya
Journal:  J Cardiovasc Dev Dis       Date:  2016-08-11

7.  Serum response factor deletion 5 regulates phospholamban phosphorylation and calcium uptake.

Authors:  Kathleen C Woulfe; Danielle A Jeffrey; Julie Pires Da Silva; Cortney E Wilson; Jennifer H Mahaffey; Edward Lau; Dobromir Slavov; Frehiwet Hailu; Anis Karimpour-Fard; Karen Dockstader; Michael R Bristow; Brian L Stauffer; Shelley D Miyamoto; Carmen C Sucharov
Journal:  J Mol Cell Cardiol       Date:  2021-06-15       Impact factor: 5.763

8.  A Hypothesis for Examining Skeletal Muscle Biopsy-Derived Sarcolemmal nNOSμ as Surrogate for Enteric nNOSα Function.

Authors:  Arun Chaudhury
Journal:  Front Med (Lausanne)       Date:  2015-07-28

9.  The LIM domain protein nTRIP6 acts as a co-repressor for the transcription factor MEF2C in myoblasts.

Authors:  Denise Kemler; Oliver Dahley; Sven Roßwag; Margarethe Litfin; Olivier Kassel
Journal:  Sci Rep       Date:  2016-06-13       Impact factor: 4.379

10.  G9a inhibits MEF2C activity to control sarcomere assembly.

Authors:  Jin Rong Ow; Monica Palanichamy Kala; Vinay Kumar Rao; Min Hee Choi; Narendra Bharathy; Reshma Taneja
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.